MRM Stock Overview
Provides holistic health services in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
MEDIROM Healthcare Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.91 |
| 52 Week High | US$8.39 |
| 52 Week Low | US$0.34 |
| Beta | 0.47 |
| 1 Month Change | 14.28% |
| 3 Month Change | 0.20% |
| 1 Year Change | -83.38% |
| 3 Year Change | -87.66% |
| 5 Year Change | n/a |
| Change since IPO | -93.95% |
Recent News & Updates
MEDIROM Healthcare Technologies' (NASDAQ:MRM) Earnings Might Be Weaker Than You Think
May 07
Further Upside For MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Shares Could Introduce Price Risks After 25% Bounce
Apr 17MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Mar 02Slammed 25% MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Screens Well Here But There Might Be A Catch
Mar 02Recent updates
MEDIROM Healthcare Technologies' (NASDAQ:MRM) Earnings Might Be Weaker Than You Think
May 07Further Upside For MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Shares Could Introduce Price Risks After 25% Bounce
Apr 17MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Mar 02Slammed 25% MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Screens Well Here But There Might Be A Catch
Mar 02Market Cool On MEDIROM Healthcare Technologies Inc.'s (NASDAQ:MRM) Revenues Pushing Shares 27% Lower
Nov 16Some MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Shareholders Look For Exit As Shares Take 41% Pounding
Sep 26There's Reason For Concern Over MEDIROM Healthcare Technologies Inc.'s (NASDAQ:MRM) Price
Aug 02MEDIROM Healthcare Technologies' (NASDAQ:MRM) Returns On Capital Not Reflecting Well On The Business
Dec 14Potential Upside For MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Not Without Risk
Aug 30Medirom Healthcare receives non-compliance letter from Nasdaq
Jul 01Shareholder Returns
| MRM | US Consumer Services | US Market | |
|---|---|---|---|
| 7D | 7.7% | 7.8% | 1.3% |
| 1Y | -83.4% | 15.6% | 8.2% |
Return vs Industry: MRM underperformed the US Consumer Services industry which returned 15.6% over the past year.
Return vs Market: MRM underperformed the US Market which returned 8.2% over the past year.
Price Volatility
| MRM volatility | |
|---|---|
| MRM Average Weekly Movement | 35.8% |
| Consumer Services Industry Average Movement | 10.3% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: MRM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MRM's weekly volatility has increased from 30% to 36% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 645 | Kouji Eguchi | medirom.co.jp |
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns, develops, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.
MEDIROM Healthcare Technologies Inc. Fundamentals Summary
| MRM fundamental statistics | |
|---|---|
| Market cap | US$6.48m |
| Earnings (TTM) | US$1.02m |
| Revenue (TTM) | US$57.12m |
7.1x
P/E Ratio0.1x
P/S RatioIs MRM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRM income statement (TTM) | |
|---|---|
| Revenue | JP¥8.30b |
| Cost of Revenue | JP¥6.05b |
| Gross Profit | JP¥2.25b |
| Other Expenses | JP¥2.10b |
| Earnings | JP¥148.76m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 18.83 |
| Gross Margin | 27.07% |
| Net Profit Margin | 1.79% |
| Debt/Equity Ratio | 190.0% |
How did MRM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/09 23:24 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MEDIROM Healthcare Technologies Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ashok Kumar | ThinkEquity LLC |